| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99222 |
Initial hospital care, per day, moderate complexity |
9,516 |
8,977 |
$972K |
| 99223 |
Prolong inpt eval add15 m |
4,547 |
4,247 |
$596K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,909 |
10,736 |
$536K |
| 99233 |
Prolong inpt eval add15 m |
5,671 |
2,973 |
$322K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
4,681 |
2,680 |
$240K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,117 |
4,525 |
$132K |
| 99236 |
Prolong inpt eval add15 m |
532 |
481 |
$92K |
| 99235 |
|
220 |
202 |
$31K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
304 |
303 |
$21K |
| 99350 |
Prolong home eval add 15m |
632 |
573 |
$21K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,604 |
1,390 |
$19K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
180 |
180 |
$13K |
| 80053 |
Comprehensive metabolic panel |
1,840 |
1,783 |
$12K |
| 80061 |
Lipid panel |
1,635 |
1,590 |
$11K |
| 99423 |
|
459 |
366 |
$9K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,616 |
1,563 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,038 |
1,015 |
$7K |
| 99497 |
|
273 |
264 |
$6K |
| Q3014 |
Telehealth originating site facility fee |
862 |
779 |
$5K |
| 80305 |
|
509 |
465 |
$4K |
| 93000 |
|
429 |
416 |
$3K |
| 81002 |
|
1,746 |
1,664 |
$3K |
| 99422 |
|
369 |
346 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
223 |
108 |
$3K |
| 99406 |
|
1,263 |
1,207 |
$2K |
| 96125 |
|
64 |
62 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
44 |
42 |
$2K |
| 86328 |
|
34 |
33 |
$2K |
| 99490 |
Ccm add 20min |
157 |
151 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
3,797 |
3,612 |
$1K |
| 82274 |
|
85 |
80 |
$568.11 |
| 3044F |
|
1,132 |
1,064 |
$560.21 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
268 |
242 |
$436.96 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
99 |
96 |
$357.90 |
| 87430 |
|
24 |
24 |
$225.40 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
42 |
39 |
$211.74 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
229 |
223 |
$166.60 |
| 82043 |
|
73 |
72 |
$158.73 |
| 92551 |
|
27 |
27 |
$140.73 |
| 82570 |
|
71 |
70 |
$124.94 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
96 |
95 |
$100.31 |
| 99173 |
|
28 |
28 |
$96.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
25 |
25 |
$83.59 |
| 99421 |
|
13 |
13 |
$74.97 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
21 |
20 |
$50.00 |
| 83735 |
|
12 |
12 |
$48.69 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13 |
12 |
$12.44 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
6,102 |
5,253 |
$1.03 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
6,694 |
5,946 |
$0.47 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
5,392 |
4,834 |
$0.37 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
465 |
447 |
$0.18 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
526 |
510 |
$0.08 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
1,626 |
1,474 |
$0.07 |
| 1126F |
|
5,027 |
4,246 |
$0.06 |
| 2000F |
|
16,554 |
13,525 |
$0.06 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
255 |
251 |
$0.05 |
| 3008F |
|
10,510 |
8,470 |
$0.05 |
| 1160F |
|
1,530 |
1,330 |
$0.04 |
| 1159F |
|
359 |
297 |
$0.03 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
167 |
163 |
$0.03 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
193 |
188 |
$0.02 |
| G8734 |
Elder maltreatment screen documented as negative, follow-up is not required |
184 |
180 |
$0.01 |
| 3288F |
|
1,536 |
1,475 |
$0.00 |
| 1494F |
|
1,294 |
1,255 |
$0.00 |
| 3077F |
|
132 |
131 |
$0.00 |
| 1090F |
|
1,600 |
1,533 |
$0.00 |
| 3078F |
|
1,274 |
1,257 |
$0.00 |
| 1124F |
|
1,167 |
1,122 |
$0.00 |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
12 |
12 |
$0.00 |
| 99072 |
|
3,401 |
2,843 |
$0.00 |
| 3050F |
|
29 |
29 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
19 |
19 |
$0.00 |
| G8484 |
Influenza immunization was not administered, reason not given |
166 |
165 |
$0.00 |
| 3016F |
|
234 |
218 |
$0.00 |
| 1125F |
|
94 |
86 |
$0.00 |
| 1006F |
|
316 |
275 |
$0.00 |
| 3048F |
|
767 |
744 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
434 |
402 |
$0.00 |
| 1101F |
|
1,533 |
1,470 |
$0.00 |
| 3074F |
|
1,249 |
1,230 |
$0.00 |
| 3075F |
|
349 |
342 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
67 |
66 |
$0.00 |
| 3080F |
|
93 |
92 |
$0.00 |
| 3079F |
|
342 |
336 |
$0.00 |
| 1123F |
|
70 |
68 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
21 |
21 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
25 |
13 |
$0.00 |
| 3049F |
|
98 |
97 |
$0.00 |
| 82962 |
|
42 |
40 |
$0.00 |
| 3017F |
|
86 |
82 |
$0.00 |
| G8432 |
Depression screening not documented, reason not given |
15 |
15 |
$0.00 |